In episode 111, Kevin Ali, CEO of Organon, talks about how’s he’s lead the launch of a new niche company for women’s health, and what he hopes it can achieve.
A flurry of new titles entering the executive ranks has its pros and cons.
Tremeau CEO Bradford Sippy strikes a new chord with revival of old blockbuster drug—modifying it as a unique treatment for orphan hemophilia condition.
Tips for surviving a shift in executive roles.
Pharma workforce shifting amidst rise of technology in healthcare.
Ken Winell, chief technology officer of Greater Than One, talks about the metaverse and the potential it has to serve the pharma industry.